Introduction
Little is known about the influence of hospital admission on sleep before operation. We have found, however, that many patients complain that sleep is disturbed before even minor operations. Alterations in preoperative sleep have been reported before open heart surgery, but severe disruption of sleep occurred only after operation.' Data on patients undergoing non-cardiac operations are sparse. Detailed observations on 10 patients undergoing elective herniorrhaphy showed decreased sleep time and reductions in the durations of rapid eye movement and deep sleep before operation.2 These minor changes were attributed to anxiety, fear, and the presence of a new environment that inhibited the duration and depth of sleep. In view of the lack of knowledge concerning disturbance of sleep and the value of hypnotics before operation we undertook a randomised double-blind controlled trial to compare a hypnotic with a short half life (triazolam)3 and one with a long half life (flurazepam)4 against a placebo before elective operation.
Patients and methods
All patients under the care of one surgeon admitted to two surgical wards were included in the trial provided that they were undergoing elective operation and were aged 18-65 years. Patients were excluded if they had recently been prescribed anticonvulsants, antihistamines, or appetite suppressants; if they had been habitually taking 5 mg or more of nitrazepam or 15 mg or more of flurazepam; and if they had taken any hypnotic or benzodiazepine within three days of the operation. We explained to all patients that a capsule was being prescribed that might improve the duration and quality of sleep on the night before operation.
A questionnaire was given to the patients before the trial drug was administered so that they could study the document and were aware of the questions that they had to answer the next morning. Patients considered suitable for inclusion in the trial were allocated at random to receive one of the following: triazolam 0-25 mg, flurazepam 15 mg, and placebo. These were all presented in identical capsules. The medication was administered half an hour before lights out. The night nurses who dispensed the drugs were also given a simple questionnaire for each patient enrolled in the trial. The patients were checked hourly to ascertain whether they were asleep. Nurses were asked to assess the overall quality of the patients' sleep as bad, reasonable, or very good.
The patient questionnaire asked the following questions: (1) Did the capsule help you sleep ? (2) How often did you wake during the night ? (3) How quickly did you fall asleep? (4) How long do you think you slept? (5) How do you feel this morning? (6) Were you satisfied with your night's sleep ?
The study was confined to the immediate preoperative period, and we did not attempt to evaluate the long-term effects of single-dose treatment.
Results
The study included 108 patients, but 12 had to be excluded because they had been habitually taking hypnotics or had taken a hypnotic within three days of admission; thus we present data on 96 patients. Table I shows the distribution of patients and compares the groups for age, sex, and operation.
The results of the nurses' questionnaire indicated that eight patients given placebo (26% of those for whom data were complete) were considered to have had a poor night's sleep compared with two (6%) given flurazepam and two (6%) given triazolam. When the data were analysed using a Mann Whitney U test for ranked scores only the patients who had received triazolam were considered by the nurses to have slept significantly better than the patients given placebo (table II) .
In answer to the question "Were you satisfied with your night's sleep ?" only 13 of the 33 patients who had received placebo had had a good night's sleep ( When duration of sleep was evaluated 22 patients who had received placebo (67°s) said that they had slept for a shorter time than usual compared with 12 (40°0) who had received flurazepam (p < 0 05) and nine (290o/) given triazolam (p<0 001) (table IV). Frequency of wakening differed appreciably between the groups, such that 18 of the 27 patients given placebo for whom data were complete woke more than twice (67001) compared with 14 out of 29 patients given flurazepam (4800) and nine out of 31 patients given triazolam (290/ ). The differences between each group achieved significance. There were no significant differences in answer to the question "How did you feel on awakening ?" (table V) . On the other hand, even in the group given placebo 13 patients complained of drowsiness and four of headaches (table VI) .
Whether the patients had been satisfied with their night's sleep was also analysed according to whether they were to have had a major or minor operation (table I). For both major and minor operations triazolam was found to provide significantly better results than placebo (p < 0-05 and p < 0-0005 respectively), whereas flurazepam was shown to be significantly better than placebo (p <0-05) only before minor operations (table III) . There was no evidence that either hypnotic was associated with any increased incidence of side effects compared with placebo. Interestingly, even when placebo was given 13 of the 31 patients complained of drowsiness and four of headaches. No adverse reactions to either hypnotic were recorded. Rebound insomnia has been recorded, particularly with short-term hypnotics,5 but the present study was conducted immediately before operation and no follow-up was undertaken. Even if we had followed up the patients it is unlikely that we could have evaluated rebound insomnia since the effect of operation itself has such a pronounced influence on sleep.6 Nevertheless, Nicholson7 reported that rebound insomnia is uncommon even after administration of hypnotics with short lives, and we question the relevance of this phenomenon.
We accept that the results of the present study are based on rather subjective data and that we did not measure the period of rapid eye movement, obtain electroencephalograms, or assess any other objective neurophysiological indices. Nevertheless, many of the same questions were asked in different ways. Hence the additional questions "Did the treatment help you sleep ?" and "How long did you sleep ?" provided results that were exactly the same as those elicited by the questions "Were you satisfied with the night's sleep ?" and "How did the length of sleep compare with usual ?"
Remarkably few studies have been carried out on the value of single-dose hypnotic treatment for patients before major and minor operations, although two studies have suggested that hypnotics improve the duration and quality of sleep before operation.8 9 The results of the present study leave us in no doubt that triazolam is safe and effective for patients before elective operation.
